BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22964769)

  • 1. Freezing does not decrease carbon monoxide-mediated hypercoagulation and hypofibrinolysis in human plasma.
    Nielsen VG; Hafner DT
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):784-6. PubMed ID: 22964769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin.
    Nielsen VG; Khan ES; Kirklin JK; George JF
    Thromb Res; 2010 Jul; 126(1):68-73. PubMed ID: 20406708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
    Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.
    Nielsen VG; Garza JI
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):801-5. PubMed ID: 25058038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon monoxide and nitric oxide modulate α₂-antiplasmin and plasmin activity: role of heme.
    Arkebauer MR; Kanaparthy SS; Malayaman SN; Vosseller K; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):712-9. PubMed ID: 22024794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in vitro and in vivo in the rabbit.
    Nielsen VG; Arkebauer MR; Wasko KA; Malayaman SN; Vosseller K
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):104-7. PubMed ID: 22143252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron and carbon monoxide attenuate Crotalus atrox venom-enhanced tissue-type plasminogen activator-initiated fibrinolysis.
    Nielsen VG; Boyer LV; Matika RW; Amos Q; Redford DT
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):511-6. PubMed ID: 26575490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report.
    Nielsen VG; Cohen JB; Malayaman SN; Nowak M; Vosseller K
    Blood Coagul Fibrinolysis; 2011 Jul; 22(5):443-7. PubMed ID: 21451399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.
    Nielsen VG; Arkebauer MR; Vosseller K
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):657-61. PubMed ID: 21822126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombelastographic characterization of coagulation/fibrinolysis in horses: role of carboxyheme and metheme states.
    Olver CS; Nielsen VG
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):273-8. PubMed ID: 23222168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon monoxide-releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in diluted plasma in vitro.
    Nielsen VG; Green P; Green M; Martin-Ross A; Khan ES; Kirklin JK; George JF
    J Trauma; 2011 Apr; 70(4):939-47. PubMed ID: 20693919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon monoxide releasing molecule-2 attenuates the anticoagulant and amplifies the hypofibrinolytic effects of hypothermia in human plasma in vitro.
    Nielsen VG; George SJ
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):67-72. PubMed ID: 21157299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon monoxide releasing molecule-2 enhances coagulation and attenuates fibrinolysis by two mechanisms: insights gained with colloid dilution.
    Cohen JB; Persaud JM; Malayaman SN; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):60-6. PubMed ID: 21157300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon monoxide releasing molecule-2 improves protamine-mediated hypocoagulation/hyperfibrinolysis in human plasma in vitro.
    Nielsen VG; Malayaman SN; Cohen JB; Persaud JM
    J Surg Res; 2012 Apr; 173(2):232-9. PubMed ID: 20950825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):377-80. PubMed ID: 19417630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon monoxide-releasing molecule-2 enhances coagulation in rabbit plasma and decreases bleeding time in clopidogrel/aspirin-treated rabbits.
    Nielsen VG; Chawla N; Mangla D; Gomes SB; Arkebauer MR; Wasko KA; Sadacharam K; Vosseller K
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):756-9. PubMed ID: 22008906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban.
    Nielsen VG; Khan ES; Kirklin JK; George JF
    Anesth Analg; 2010 Dec; 111(6):1347-52. PubMed ID: 21048101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and factor VII-deficient plasmas.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):41-5. PubMed ID: 19923981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.